AnalystsInsight

Serge Belanger (Needham): Analyst Track Record and Price‑Target Accuracy

How often Serge Belanger’s price targets were reached, how fast, and what the stocks did after each call: a 7‑year backtest of 1,885 ratings, compared with the average Wall Street analyst.

Reviewed by:David, Senior AnalystPublished Oct 12, 2026Updated Oct 18, 20263 min readHow we research

What changed since Oct 12

Exent re-checks this page every day. Ratings appear 30 days after they are published; live calls are in Gems.

#1135 rank (was #1365)+1 new rating (XENE)4.5★ rating (was 4.3★)

Key takeaways

Serge Belanger ranks #938 of 1,000 analysts in Exent’s scoring (4.5★).
20.9% of price targets were reached over 7 years, versus 52.4% for the average analyst.
Median time to reach a target: 168 days; 49.0% of calls were up 12 months later.
Most‑covered stocks: VRDN, CYTK, CRMD, COLL.
Free on Exent: Serge Belanger’s full record, with ratings 3 days after publication.

In this article

Serge Belanger’s track record at a glance
How fast price targets were reached
Stocks Serge Belanger covers most
Serge Belanger’s latest ratings
How Exent scores analysts

Serge Belanger’s track record at a glance

Serge Belanger of Needham ranks #938 of the 1,000 analysts Exent scores, with a 4.5★ rating and a focus on healthcare. Over a 7‑year lookback, 20.9% of Serge’s price targets were reached, 31.5 points below the 52.4% average across all analysts.

Metric	Serge Belanger	All analysts
Price‑target hit rate	20.9%	52.4%
Median days to hit target	168 days	91 days
Calls up after 12 months	49.0%	64.0%
Median 12‑month return of calls	−1.0%	+13.4%
Hit rate, last 2 years	28.9%	—
Average worst drop after a call	−32.1%	—
Ratings in the sample	1,885	—
Stocks covered	26	—

The full records of Exent’s top 90 analysts and the top 50 of each sector, and the stocks where several of them agree right now, are members‑only in Exent Gems.

See the top-ranked analysts in Gems

How fast price targets were reached

Time to reach the target	Serge Belanger
Under 30 days	8.4%
30–90 days	18.6%
90–180 days	27.2%
Over 180 days	45.8%

Share of the targets that were reached, by how long they took. Targets are usually set for 12 months.

Stocks Serge Belanger covers most

Stock	Ratings in the sample
VRDN	34
CYTK	28
CRMD	23
COLL	21
XENE	20
OCUL	20
MLTX	20
OMER	19

In the past year Serge’s ratings were 82% Buy, 18% Hold and 0% Sell.

Serge Belanger’s latest ratings

Date	Stock	Action	Rating	Price target
Sep 18, 2026	XENE	Reiterated: Buy	Buy	$60.00
Sep 9, 2026	EVMN	Reiterated: Buy	Buy	$28.00
Sep 8, 2026	BCRX	Reiterated: Buy	Buy	$16.00
Aug 28, 2026	CYTK	Reiterated: Buy	Buy	$112.00
Aug 27, 2026	VRCA	Reiterated: Hold	Hold	$0.00
Aug 26, 2026	EVMN	Initiated Coverage: Buy	Buy	$28.00
Aug 17, 2026	OCUL	Reiterated: Buy	Buy	$18.00
Aug 13, 2026	OMER	Reiterated: Hold	Hold	$0.00
Aug 13, 2026	CRMD	Reiterated: Buy	Buy	$15.00
Aug 12, 2026	MANE	Reiterated: Buy	Buy	$164.00
Aug 12, 2026	LQDA	Reiterated: Buy	Buy	$110.00
Aug 10, 2026	MLTX	Reiterated: Buy	Buy	$30.00

Sep 18, 2026
Stock
XENE
Action
Reiterated: Buy
Rating
Buy
Price target
$60.00
Sep 9, 2026
Stock
EVMN
Action
Reiterated: Buy
Rating
Buy
Price target
$28.00
Sep 8, 2026
Stock
BCRX
Action
Reiterated: Buy
Rating
Buy
Price target
$16.00
Aug 28, 2026
Stock
CYTK
Action
Reiterated: Buy
Rating
Buy
Price target
$112.00
Aug 27, 2026
Stock
VRCA
Action
Reiterated: Hold
Rating
Hold
Price target
$0.00
Aug 26, 2026
Stock
EVMN
Action
Initiated Coverage: Buy
Rating
Buy
Price target
$28.00
Aug 17, 2026
Stock
OCUL
Action
Reiterated: Buy
Rating
Buy
Price target
$18.00
Aug 13, 2026
Stock
OMER
Action
Reiterated: Hold
Rating
Hold
Price target
$0.00
Aug 13, 2026
Stock
CRMD
Action
Reiterated: Buy
Rating
Buy
Price target
$15.00
Aug 12, 2026
Stock
MANE
Action
Reiterated: Buy
Rating
Buy
Price target
$164.00
Aug 12, 2026
Stock
LQDA
Action
Reiterated: Buy
Rating
Buy
Price target
$110.00
Aug 10, 2026
Stock
MLTX
Action
Reiterated: Buy
Rating
Buy
Price target
$30.00

Serge’s ratings are free on Exent 3 days after publication. Exent Gems has them the same day, with the calls of the top‑ranked analysts and the stocks where several of them agree.

See the top-ranked analysts in Gems

How Exent scores analysts

Exent replays every rating with a price target over a 7‑year lookback: was the target reached, how long it took, and what the stock returned 1, 3, 6 and 12 months after the call. The star rating and rank combine success rate, average return and the number of ratings, so a few lucky calls do not make a top analyst. Statistics as of Jun 24, 2026; ranking updated Oct 20, 2026. How accurate are analyst price targets overall?

Past performance does not guarantee future results. Historical figures are calculated by Exent from market data and are for education only; they are not investment advice or a recommendation to buy or sell any security.

Follow the analysts with the best records

Exent Gems shows Serge Belanger’s live ratings and those of the top‑ranked analysts, without the 30‑day delay used on this page.
Gems are the stocks where several 4★+ analysts agree: Exent’s shortlist of high‑conviction ideas.
Check any idea against your own portfolio: correlation, concentration and crash exposure before you buy.

See this week’s Gems

Exent is our product. Educational content, not investment advice.

Frequently asked questions

By Exent’s scoring Serge Belanger ranks #938 of 1,000 with a 4.5★ rating. 20.9% of price targets were reached over a 7-year lookback (all analysts: 52.4%), and 49.0% of calls were up 12 months later. Past accuracy does not guarantee future accuracy.

Serge Belanger’s success rate is 43.2% by the ranking source and 20.9% by Exent’s price-target hit-rate backtest, with a median of 168 days to reach a target.

Serge Belanger (Needham) covers 26 stocks, mostly in healthcare. The most frequently rated are VRDN, CYTK, CRMD, COLL, XENE.

: .-++++=: .-=+**+-. .:=+*#*=:..::-+##*+-:. .-+**+++=:. .:::-=+**********++===++***+++*###*+=--:. .:==+*#*+-:..::-+##*+-:. :=**++=: .-=+**+-. .:=+*#*-...: . -++*+=: .:=+**+-. .:-+*#*=:..::=+##*=-:...:=***++=:. .:-=+*###*++==--:::::::...:---==+*##**++=-. .:-=+###*=-:...-+**++=: :=++*+-. :-=***=:..:-=*##+-..: :=+*++-. :=++*+=. :-=*#*+-..::=+##*=-:...-+*#*+=-. :-=+*###*+=--:. .... .::..:-=+++****=-:..::-=*#*+=-: .-=++++=. .-=+**+-...:=+##*=:.::-+##*=::. .-++++=: .-=+**=: .-=+*#+-...:-+##*=-::.:-+##*+=:. .-=++***+=-:::.. ..:-----:::::::. .:-=+*###*=-:.. :=+**++-. .-=+**+-. .:-+*##+:..:-=*##+-:..:=*#*+-:. :=+*++-. :=+**+-. .:=+*#*-...:-+*##+-:.::-+##*=-:. :=++**++-:...::::-==+++++****++===-:....:::-+*#*+==:. .-=+**+-. .:-=*##+-:.::-+##*=::.:-+##*=-:..-+#*+=:. .-++++=: .-++**=: :-=***=:..:-=*##+-:.::-+##*=-:...:=***++-: .:-==*###**+**####*******+=-::...:-+**++=-. :-=+##*-:..:-+###+-:..:=*#*+-:..:=*#*=-: :=**+=-. :=++++-. :=+**+-. .-=+**+-...-=+##*-:.::-+##*=-:...-+***+=-. .:-=+*####*+==========++*###*+=-:. .-=+***+-...:-=*##+-::.:-*##+=-:..-+#*+=-. .-+**+=: .-++++=: :=+*+=: .-=+**=: :-+***=: .:-+*#*=:..:-+###+-::.:-+##*=-:. .-=++****+---::. .::::--+****++=-. .:-+*##+-::.:-+##*=-:..:=*#*+-: .=**++-. :=+*++-. :=+**+: -++*+=. :=+**+-. .-=+**+-..:-=*##+-..:-=*##+-::.:-+##*=-:. :=+++*++-:...:.. ...:.. .:-=+**#*=:..::-+##*+-:...-+#*+=-. -+**+=: .-++*+=: .-++*+=. :=+**+- =+**+- .-=+**=: :-=*#*=:..:-+*#*=:.::-+##*=::.:-+##*=-:. .-+**++=-: .::---====---:. .::-=*##*=-:...-+##+=-: :=+*++-. .=++++-. :=+**+-. .-=+**+: .:-=*#*= =+**=: :-=***=. .:=+*#+-..:-=*##+-..:-=*##+-:.::=*##+-:...-+**++=:. .:-==+*###*+++++=-:..:::=*##*=-:. .-+**+=: -=+*+=: .-=+**=: :-=*#*=. .:=+*#+-..:-=*##+ =+**=. .:=+**+-. .-=*##+:..:-+*#*=:.::-+##*-::::=*##+=::..-+##*=-: :-=++*###**+++*###*=-::. .-+**+=-. :=++*+=. :-+**+-. .:=+*#+-..:-=*##+:..:-+##*=:.::=*##+ +**+-. .-=+**+:..:-+*#*=:..:=+##+-:.:-=*##+-:.:-+##*=-:..:+*#*=-:. .:=++***+=------=+*##*+=-. .-++*+=: .-=+**+: .-=*#*=:..:-+*#*=:.::=*##+-:.:-+##*=::.:-*##+ +**+-. :-=*#*=:..:-+##*-..:-=*##+-:.:-+##*=::.:-*##+-:..:=*#*+-:. .-+**++=-:. ..:...:-=+*++=-. :-+***=. .:-+*#*-...:=+##+-..:-=*#*=::::-+##+-::.:=*#*=-:..-+##+ +*#+:..:-+*#*=:..:=*##+-:.:-+##*=::::-*##+-:..:=*#*=-:..:+##+=-. .:+**++-: .::::. :-++**+:. .-=+##+:..:-=*#*=:..:-+##*-::::=*##+-:.:-+##*=::.:=*#*+-:..:+##+ *##+:..:-+##*-:.::=*##+-:::-+##*=::.:=*##+-:..-+##*=-...-*#*+-:. .=***+-: :-====-: .:-+*#*=:..:-+##*-:.::=*##+-:.:-+##*=::.:=*##+-:..:+##+=-...-*#*+-:. :+**+ *##=:..:-+##*-:.::=*##=-:.:-+##+-:..:=*#*=-:..-+##+=:. :=*#*=-: :+**+=:. .-=++**#*+-..:-=*##+-:.:-+##*=::.:=*##+-:..:+##*=-:..-*#*+-:..:+**+=-. .-***+-: :=**+ *##=::::-+##+-::::=##*=-:.:-*##+-:..:=##*=-:..-+#*+-:. :=**+=-. .-+**+=: :=+*+++##*=::::=*##+-:.::+##*=-:.:-*##+-:..:+##*=-...-*#*+-: :=**+=-. .-+*++-. :=+*+ ##*=::.:-*##+-:..:=##*=-:..-*#*+-:..:=*#+=-. .-+**+-: :=**+=-. .-+*++=. :=++++*##*=::.:=*##+-:..:+##*=-:..-*#*+-:..:+**+=-. .-***+-: :=**+=: .-+*++-. :=+++ ##*=-:..-*##+-:..:=*#*=-...-+#*+-:. :=**+=-. .-+**+=: .=+*+=-. -=+*+=: .-=+*###*=-:..:=*#*=-:..-+##+=:...=*#*=-: :+**+=:. .-+*++-. :=**+=: .-++++-. :=+** ##*=-:..-+#*+-:. :=**+=-. .-+**+=: .=**+=-. :++++=: .-++*+-. :=+**+-. .:--=++=-:::.:-*##+=:...-*#*+-:. :=**+=-. -+**+=: .=+*+=-. :=+++=: .-++*+-. .-=+** *#*=-: .-+**+=:. .=**+=-. :+**+=: .-++++-. :=+**+: .-=+**=: :-=+##+-:...........::-+##*=-:..:=*#*=-. :+**+=:. .-+*++-. :=+*+=- .-++*+=. :=+**+- .-=+** ***=-. :+**+=: .-+*++-. :=+++=: .-=+*+=. :-+**+-. .:=+*#*-:..:-+*##*=--:. .:--=*##*=-:...-*#*+=:. .-+**+-: .=+*+=-. :=+*+=: .-++*+-. :=+**+: :-=*** +*++-. :=+*+=: .-++*+=. :=+**+-. .:=+**+: :-=*#*+:..:-=*##+-::.:-=*##*+==------==+*##*=-:...-+##+=-. :+**+=-. :++*+=: .-++*+=. :=+**+-. .-=+**=: .:-+*#* ++++=: :=++*+-. .:=+**=: .-=***=. .:-+*#*-...:=+##*=::::-+##*+-:.. .-++++**##***++**#*+-::..:-+##*=-:. .=***+=: .-+*++-. :=++*+-. .-=+**+: :-=*#*=. .:=+##+ =+*+=: .-++**=. .:=+**+-. .-=+##+-..:-=*##+-:.:-=*##+-:...-+##*+=:. .:-==+*###**++++=-:..:::=*##*=-:. .-+**+=:. :=+*+=: .-=+**=: .-=***=. .:=+*#+-..:-=*##+ =+**+-. .-=+**=:..:-+*#*=:..:-+##*=:.::-+##*=::..-+##*=-:. .-++*+++-: .::::--====--:. .::-+*##*=-:. .-+**+=-. :=+*++-. :=++*+-. .:=+**+-. .-=+##+:..:-+*#*= -+*#*=...:=+##+-..:-=*##+-:.:-=###+-:..:=*#*+-:. .-+**+=-. .:=++*#*+-:::.. .::.. .:--=+###*=-:...-+**+=-: .-+*++=: .-=+**=: .-=+**=: .:-+*#*=:..:=+##*- -=*##=:..:-+##*=::::-+##*=::..-*##+=-. .-+**+=-. .-++**+-. .:-=*###*+=--:.....:::..:--=++*##*+-::..:-+##*=-: .-+**+=-. :=+**+-. .:=+*#+-...-=+##+-..:-=*##+- :=*##+-::::=*##+-:..:=*#*=-:. :=***+-: .-++++=-. :-=+*#*=:..:::-=****++*+++======++********=-:..::-=*##*=-:. .-+**++-. .-++**=: :-=***=:..:-=*#*=:..:-+##*=: :-+##*=-:..-+##+=-. .-+**+=:. :++*++-. :-++**+-. .:-=*##*+--:. .:==++*####**++*####**++==:. .:--+###*=-:. .-+**++-: .-=+**+: .-=+*#+-...-=+##+-..:-=*##+-: .:=*#*=-:. :=**+=-: :=+*++-. .-=+**+:. .:-+*##+-:::::=+##*+=-:. .:--==+**++++****+==--: :--=*###+=-:...-+**++-: .-=+**+-. :-+***=:..:-+*#*=:..:-+##*=:: .-+**+=:. .-+**+=: .-=+**+-. .:-+*#*+:..::-+###+=-:. .:=+***++=-:........::-----::::::.. :-==+*##*=-::..:=*#*+=-: .:=++++-. :-=+**+:..:-=*##+-..:-=*##+-:: :=+*++-. :=++*+=. :-=***+-..::=+##*=-::.:-+*#*+=-: :-=+*###*+=--:. ..:. .:::::-=+++****=-:..::-=*##+=-:. .-=+*++=: .-=+**+-. .:=+##*=:.::-+##*=::. .-=+**=: .-=+**+-...:-+##*=-::::=*##*=-:. .:=+*+++=:. .::-=+*##**++==--::::::...::---=+**#**+++=:. ..:-=+###+=-:. .-+**++=: .-=+**+-. .:-+*#*=:..:-=*##+-::: . :-+***=:..:-=*##+-:.::=*##*=-:..:-+**+=-: :-=+*#*+=:::...:-=++++*###**++=+++++++++**###*+==-:. .:-=+*##*+-::...-+**++-: .:=+**+=. :-=*##+-..::=*##*-::.:

Get the picks Wall Street’s best analysts agree on.

Exent tracks 4,000+ analysts, keeps only the elite few with proven records, and surfaces the Gems where they agree.

See this week’s GemsLimited offer$1.95 for full access· full access

Educational content, not investment advice. Examples are illustrative; past performance does not guarantee future results.

DISCLAIMER: Exent AI is an informational research platform and does not provide investment advice, financial advice, or act as an investment adviser, broker-dealer, or fiduciary. All content, analytics, and model outputs are provided for educational and informational purposes only and should not be relied upon as a recommendation to buy, sell, or hold any financial instrument. Investing involves risk, including the possible loss of principal. Exent AI does not execute trades, hold customer funds, or provide brokerage services. Past performance and hypothetical results are not indicative of future results. Third-party data and AI-generated outputs may be incomplete or inaccurate.

What changed since Oct 12

Key takeaways

Are Analyst Price Targets Accurate? 7 Years of Data

How to Follow Wall Street Analysts the Smart Way: Track Records, Not Headlines

What Are Exent Gems? Top‑Analyst Agreement Explained